F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Infliximab

Page 1 of 2 ( 83 items )
<<
1
2
>>

1	Determination of correlation of clearance with clinical outcomes for inflammatory bowel disease 1/28/2026 9:23:38 AM \| Browse: 108 \| Download: 363
2	Endometrial stromal sarcoma in a patient with ulcerative colitis receiving immunosuppressive therapy: A case report and review of literature 12/16/2025 6:42:01 AM \| Browse: 138 \| Download: 423
3	Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges 11/13/2025 6:51:08 AM \| Browse: 159 \| Download: 365
4	Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab 7/21/2025 9:42:33 AM \| Browse: 145 \| Download: 766
5	Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients 6/6/2025 3:09:39 AM \| Browse: 246 \| Download: 963
6	Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review 3/18/2025 4:25:39 AM \| Browse: 246 \| Download: 719
7	Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis 7/11/2024 9:22:47 AM \| Browse: 346 \| Download: 828
8	Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report 3/25/2024 8:14:32 AM \| Browse: 283 \| Download: 991
9	Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease 3/25/2024 2:43:27 AM \| Browse: 342 \| Download: 1457
10	Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis 2/25/2024 3:12:20 PM \| Browse: 334 \| Download: 1434
11	Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology 7/27/2023 1:26:07 AM \| Browse: 273 \| Download: 1086
12	Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease 5/11/2023 8:05:04 AM \| Browse: 459 \| Download: 1132
13	Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults 4/24/2023 11:14:10 AM \| Browse: 572 \| Download: 1408
14	Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports 1/20/2023 1:48:21 PM \| Browse: 620 \| Download: 2081
15	Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report 12/14/2022 7:20:14 AM \| Browse: 460 \| Download: 1348
16	Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation 11/25/2022 11:36:34 AM \| Browse: 600 \| Download: 1644
17	Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease 8/10/2022 8:23:14 AM \| Browse: 759 \| Download: 2707
18	How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study 7/27/2022 2:48:54 AM \| Browse: 862 \| Download: 2049
19	Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis 6/17/2022 3:19:26 AM \| Browse: 738 \| Download: 2252
20	Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients 5/13/2022 8:46:12 AM \| Browse: 668 \| Download: 1806
21	Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review 12/29/2021 9:44:51 AM \| Browse: 788 \| Download: 1617
22	Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease 12/23/2021 2:14:14 PM \| Browse: 757 \| Download: 2608
23	Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature 11/22/2021 10:34:53 AM \| Browse: 808 \| Download: 1768
24	Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature 8/31/2021 6:51:26 AM \| Browse: 688 \| Download: 1390
25	Approach to medical therapy in perianal Crohn’s disease 7/6/2021 2:31:17 AM \| Browse: 794 \| Download: 1427
26	Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report 6/24/2021 7:26:33 AM \| Browse: 822 \| Download: 1933
27	Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report 6/24/2021 7:26:33 AM \| Browse: 652 \| Download: 2375
28	Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports 5/11/2021 11:07:20 AM \| Browse: 745 \| Download: 1813
29	Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report 4/22/2021 12:14:43 PM \| Browse: 798 \| Download: 2178
30	Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report 4/9/2021 8:11:26 AM \| Browse: 961 \| Download: 2344
31	Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review 3/3/2021 10:02:01 AM \| Browse: 998 \| Download: 2563
32	Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report 12/14/2020 8:10:05 AM \| Browse: 1163 \| Download: 2408
33	First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 11/20/2020 4:04:17 AM \| Browse: 1181 \| Download: 2731
34	Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China 11/6/2020 7:36:12 AM \| Browse: 1150 \| Download: 3113
35	Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability 9/24/2020 6:20:22 AM \| Browse: 1203 \| Download: 3118
36	Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report 9/22/2020 3:17:13 AM \| Browse: 1139 \| Download: 1770
37	Severe steroid refractory gastritis induced by Nivolumab: A case report 4/28/2020 8:04:31 AM \| Browse: 1286 \| Download: 2584
38	Optimized timing of using infliximab in perianal fistulizing Crohn's disease 4/14/2020 12:30:24 PM \| Browse: 1105 \| Download: 2246
39	Crohn’s-like acute severe colitis associated with Hermansky-Pudlak syndrome: A case report 2/27/2019 4:11:15 AM \| Browse: 1359 \| Download: 2380
40	Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report 1/21/2019 9:20:19 AM \| Browse: 1533 \| Download: 2179
41	Biosimilars in paediatric inflammatory bowel disease 9/20/2018 2:33:54 AM \| Browse: 1411 \| Download: 1988
42	Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting 2/2/2018 8:28:46 AM \| Browse: 1394 \| Download: 2352
43	Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy 9/14/2017 3:13:08 AM \| Browse: 1351 \| Download: 1932
44	Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature 8/1/2017 12:23:47 AM \| Browse: 1515 \| Download: 2398
45	Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study 6/14/2017 9:25:57 AM \| Browse: 1562 \| Download: 2922
46	Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study 5/4/2017 8:16:34 AM \| Browse: 1248 \| Download: 2013
47	Combination therapy for inflammatory bowel disease 5/4/2017 8:16:34 AM \| Browse: 1613 \| Download: 2338
48	Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis 3/19/2017 6:44:00 PM \| Browse: 1464 \| Download: 3129
49	Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease 2/26/2017 6:20:00 PM \| Browse: 1561 \| Download: 3274
50	Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies 1/5/2017 11:10:00 AM \| Browse: 1208 \| Download: 2503

Page 1 of 2 ( 83 items )
<<
1
2
>>

1	Determination of correlation of clearance with clinical outcomes for inflammatory bowel disease 1/28/2026 9:23:38 AM \| Browse: 108 \| Download: 363
2	Endometrial stromal sarcoma in a patient with ulcerative colitis receiving immunosuppressive therapy: A case report and review of literature 12/16/2025 6:42:01 AM \| Browse: 138 \| Download: 423
3	Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges 11/13/2025 6:51:08 AM \| Browse: 159 \| Download: 365
4	Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab 7/21/2025 9:42:33 AM \| Browse: 145 \| Download: 766
5	Longitudinal computed tomography-based delta-radiomics of visceral adipose tissue predicts infliximab secondary loss of response in Crohn’s disease patients 6/6/2025 3:09:39 AM \| Browse: 246 \| Download: 963
6	Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review 3/18/2025 4:25:39 AM \| Browse: 246 \| Download: 719
7	Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis 7/11/2024 9:22:47 AM \| Browse: 346 \| Download: 828
8	Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report 3/25/2024 8:14:32 AM \| Browse: 283 \| Download: 991
9	Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease 3/25/2024 2:43:27 AM \| Browse: 342 \| Download: 1457
10	Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis 2/25/2024 3:12:20 PM \| Browse: 334 \| Download: 1434
11	Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology 7/27/2023 1:26:07 AM \| Browse: 273 \| Download: 1086
12	Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease 5/11/2023 8:05:04 AM \| Browse: 459 \| Download: 1132
13	Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults 4/24/2023 11:14:10 AM \| Browse: 572 \| Download: 1408
14	Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports 1/20/2023 1:48:21 PM \| Browse: 620 \| Download: 2081
15	Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report 12/14/2022 7:20:14 AM \| Browse: 460 \| Download: 1348
16	Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation 11/25/2022 11:36:34 AM \| Browse: 600 \| Download: 1644
17	Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease 8/10/2022 8:23:14 AM \| Browse: 759 \| Download: 2707
18	How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study 7/27/2022 2:48:54 AM \| Browse: 862 \| Download: 2049
19	Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis 6/17/2022 3:19:26 AM \| Browse: 738 \| Download: 2252
20	Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients 5/13/2022 8:46:12 AM \| Browse: 668 \| Download: 1806
21	Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review 12/29/2021 9:44:51 AM \| Browse: 788 \| Download: 1617
22	Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease 12/23/2021 2:14:14 PM \| Browse: 757 \| Download: 2608
23	Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature 11/22/2021 10:34:53 AM \| Browse: 808 \| Download: 1768
24	Hemorrhagic pericardial effusion following treatment with infliximab: A case report and review of literature 8/31/2021 6:51:26 AM \| Browse: 688 \| Download: 1390
25	Approach to medical therapy in perianal Crohn’s disease 7/6/2021 2:31:17 AM \| Browse: 794 \| Download: 1427
26	Infliximab treatment of glycogenosis Ib with Crohn's -like enterocolitis: A case report 6/24/2021 7:26:33 AM \| Browse: 822 \| Download: 1933
27	Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report 6/24/2021 7:26:33 AM \| Browse: 652 \| Download: 2375
28	Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports 5/11/2021 11:07:20 AM \| Browse: 745 \| Download: 1813
29	Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report 4/22/2021 12:14:43 PM \| Browse: 798 \| Download: 2178
30	Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report 4/9/2021 8:11:26 AM \| Browse: 961 \| Download: 2344
31	Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review 3/3/2021 10:02:01 AM \| Browse: 998 \| Download: 2563
32	Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report 12/14/2020 8:10:05 AM \| Browse: 1163 \| Download: 2408
33	First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 11/20/2020 4:04:17 AM \| Browse: 1181 \| Download: 2731
34	Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China 11/6/2020 7:36:12 AM \| Browse: 1150 \| Download: 3113
35	Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability 9/24/2020 6:20:22 AM \| Browse: 1203 \| Download: 3118
36	Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report 9/22/2020 3:17:13 AM \| Browse: 1139 \| Download: 1770
37	Severe steroid refractory gastritis induced by Nivolumab: A case report 4/28/2020 8:04:31 AM \| Browse: 1286 \| Download: 2584
38	Optimized timing of using infliximab in perianal fistulizing Crohn's disease 4/14/2020 12:30:24 PM \| Browse: 1105 \| Download: 2246
39	Crohn’s-like acute severe colitis associated with Hermansky-Pudlak syndrome: A case report 2/27/2019 4:11:15 AM \| Browse: 1359 \| Download: 2380
40	Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report 1/21/2019 9:20:19 AM \| Browse: 1533 \| Download: 2179
41	Biosimilars in paediatric inflammatory bowel disease 9/20/2018 2:33:54 AM \| Browse: 1411 \| Download: 1988
42	Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting 2/2/2018 8:28:46 AM \| Browse: 1394 \| Download: 2352
43	Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy 9/14/2017 3:13:08 AM \| Browse: 1351 \| Download: 1932
44	Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature 8/1/2017 12:23:47 AM \| Browse: 1515 \| Download: 2398
45	Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study 6/14/2017 9:25:57 AM \| Browse: 1562 \| Download: 2922
46	Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study 5/4/2017 8:16:34 AM \| Browse: 1248 \| Download: 2013
47	Combination therapy for inflammatory bowel disease 5/4/2017 8:16:34 AM \| Browse: 1613 \| Download: 2338
48	Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis 3/19/2017 6:44:00 PM \| Browse: 1464 \| Download: 3129
49	Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease 2/26/2017 6:20:00 PM \| Browse: 1561 \| Download: 3274
50	Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies 1/5/2017 11:10:00 AM \| Browse: 1208 \| Download: 2503